Methods for producing and purifying recombinant alpha-L-iduronidase
OwnerMinmin Qin, Wai-Pan Chan +7inventors
InventorsMinmin Qin, Wai-Pan Chan, Lin Chen, Paul Fitzpatrick, John Henstrand, Dan Wendt, Gary Zecherle, Christopher Starr, Emil Kakkis
Life of this patent
Estimating the term…
Abstract
The present invention provides a recombinant human α-L-iduronidase and biologically active fragments and muteins thereof with a purity greater than 99%. The present invention further provides large-scale methods to produce and purify commercial grade recombinant human α-L-iduronidase enzyme thereof.
Claims28
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of purifying human recombinant α-L-iduronidase, or a biologically active fragment or mutein thereof, comprising the steps of
- a) obtaining culture medium from a culture of Chinese Hamster Ovary (CHO) cells that have been transformed with a nucleic acid that encodes said human recombinant α-L-iduronidase;
- b) adjusting the pH of the culture medium to an acidic pH;
- c) subjecting said pH-adjusted medium to ultrafiltration;
- d) subjecting the filtered medium produced by step (c) to a first dye-affinity chromatography purification step;
- e) subjecting the eluant from step (d) to a first metal-ion chelate chromatography step;
- f) subjecting the eluant from step (e) to a hydrophobic interaction chromatography (HIC) step;
- and
- g) concentrating and diafiltering the eluant from step (f), to yield a purified preparation of purified human recombinant α-L-iduronidase which has a greater than 99% purity as determined by quantity of contaminating CHO protein per mg of total protein in said preparation.
The method of claim 23, wherein the medium of said cells at confluence is harvested for said purification of human recombinant α-L-iduronidase, or a biologically active fragment or mutein thereof.
The method of claim 25, wherein said continuous perfusion comprises exchanging between 2 to 3.5 culture volumes of said medium over 24 hours.
Dependencies are inferred from the claim text.